Please ensure Javascript is enabled for purposes of website accessibility

Beyond Meat Was the Vegan IPO You'd Been Waiting For, but It Won't Be the Last of Its Kind

By Maxx Chatsko – Updated May 28, 2019 at 5:05PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

More vegan, plant-based, and cultured protein products are coming.

Wall Street banks severely underestimated the popularity of plant-based foods when pricing the market debut of Beyond Meat (BYND 2.88%). The miscalculation has proved costly.

Consider that the initial public offering (IPO) included over 11 million shares priced at $25 apiece, which raised over $240 million. But shares traded hands at nearly twice that amount on the day of the IPO and are comfortably above the $70 range today. While the animal-free protein developer isn't worth its current market valuation, it probably could have raised a few hundred million dollars more.

That's OK, though. Wall Street bankers will get another chance. Many chances, actually. Beyond Meat is just the first of a wave of animal-free protein developers that are likely to splash onto public markets through IPOs and acquisitions. There are dozens of companies developing products in the space and securing investments from established food developers such as Tyson Foods (TSN -1.51%), Cargill, Archer Daniels Midland (ADM -5.13%), Awano Food Group, and Ingredion (INGR -2.54%).

Here's what the future holds for investors -- and why it's best to avoid calling it "fake meat."

A burger on a bright yellow surface

Image source: Getty Images.

What's in a name?

A burger by any other name would taste as awesome, right? Probably, but discussion of Beyond Meat and its competitors gets messy quickly. From "fake meat" to "meatless meat," "plant-based" to "vegan," investors and curious onlookers will have to wade through a number of awful and inaccurate descriptions. Sometimes it's just journalists without technical backgrounds covering technical subjects. Other times it's just that marketing teams are still figuring out how best to describe products to consumers in the early days of the field.

That said, there are three main terms that will likely come to dominate the discussion:

  1. Vegan -- The product doesn't contain animal-derived ingredients.
  2. Plant-based -- The protein source is from plants, but secondary ingredients in the product might still come from animals.
  3. Cultured -- The protein source was grown from microbes or tissue culture in a bioreactor. The microbes are usually genetically engineered, and fed plant-derived energy sources such as sugar, so sometimes companies just say "plant-based" to avoid bringing up the genetically modified organism debate. Additionally, when tissue culture is used, the product is real animal meat, but a live animal wasn't the vessel used to grow it.

In the long run, it won't matter if products are manufactured from genetically engineered microbes or considered "lab meat," only that they deliver on ideals (avoiding industrial livestock production), taste (indistinguishable from animal-derived meat), and cost.

Therefore, above all else, the most accurate way to think about the field is also the simplest: protein. The entire technology focus of the first vegan IPO was that it delivered a non-animal protein source. That's also what connects Beyond Meat to the companies that are destined to follow in its footsteps to mass-market products -- and even the public markets.

A crowd of cows standing in a field.

Image source: Getty Images.

The field is stacked

Beyond Meat's successful market debut has catalyzed interest in animal-free protein sources from established food and restaurant chains. TGI Friday's, Burger King, Chick Fil A, and Little Caesars are just a few of the major industry players exploring how to introduce new products to consumers. As that diverse list suggests, non-animal protein sources aren't confined to replacing animal-derived burgers.

Consider a sample of the companies and animal-free protein products being developed and market-tested.


Animal-Derived Product Targeted

Notable Development(s)

Beyond Meat

Plant-based beef and sausage

Successful IPO, market valuation over $4 billion

Impossible Foods

Plant-based beef, sausage, other

Burger King sells an Impossible Whopper in some cities, Little Caesars testing sausage product

JUST (formerly Hampton Creek)

Plant-based eggs and mayonnaise, cultured beef

Partnered with Awano Food Group to develop, market, and sell cultured beef products

Memphis Meats

Cultured beef, poultry

Tyson Foods purchased a stake in 2018

Clara Foods

Cultured proteins for food (egg whites) and beverages

Ingredion led its Series B fundraising round in April 2019


Cultured collagen (gelatin)

Selling collagen to cosmetics industry, 2020 launch for food

Finless Foods

Cultured seafood

Raised $3.5 million in 2018 to develop cultured bluefin tuna

Wild Earth

Cultured protein for dog food

The vegan dog market is larger than you think, apparently

Data source: Author.

That table is in no way an exhaustive list of the animal-free protein start-ups that exist, of which there are dozens, but it goes to show the diversity of the market opportunity. Not every company will succeed or make it to the public markets, but some will, while others will be acquired by established food companies.

The market is still in its infancy

Beyond Meat may have paved the way for animal-free protein on Wall Street, but it certainly will not be the only investing opportunity in animal-free protein products. That realization might chip away at the company's premium market valuation over the remainder of 2019. After all, the stock trades at an astonishing 50 times sales. That's not to suggest that the business can't thrive in the $1.4 trillion global meat market, but a lot of future growth is priced into shares right now. Investors would be better off waiting for a better entry point -- or even the next animal-free protein developer to make a splash.

Maxx Chatsko has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Beyond Meat Stock Quote
Beyond Meat
$15.69 (2.88%) $0.44
Archer-Daniels-Midland Company Stock Quote
Archer-Daniels-Midland Company
$81.65 (-5.13%) $-4.42
Tyson Foods, Inc. Stock Quote
Tyson Foods, Inc.
$69.94 (-1.51%) $-1.07
Ingredion Incorporated Stock Quote
Ingredion Incorporated
$80.10 (-2.54%) $-2.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.